Residual Embolism Evaluated With Single Photon Emission Computed Tomography

Recruiting Observational Study
Pulmonary Circulation Obstruction
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
358 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Major progress achieved in diagnostic and therapeutic strategies has substantially improved the short-term prognosis of patients with pulmonary embolism (PE). These improvements have led to a shift from an acute to a chronic condition of venous thromboembolism, justifying the recent development of Chronic Thrombo-embolic Disease (CTED). In most of the situations, it is due to a residual pulmonary …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient addressed to nuclear medicine department of Saint-Etienne public hospital for V/Q pulmonary SPECT-CT assess to rule out perfusion obstruction, admitted for a suspicion of pulmonary hypertension (PH), or a persistent dyspnea after PE * Patient affiliated ou beneficiary …
Contacts

Pierre-Benoit BONNEFOY, MD

(0)4 77 82 94 43

pierre-benoit.bonnefoy@chu-st-etienne.fr

CONTACT

NATHALIE PREVOT, MD

(0)4 77 82 94 43

nathalie.prevot@chu-st-etienne.fr

CONTACT